Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05678023

Multicentre Randomized Trial on Timing and Effect of Contrast Media in Adhesive Small Bowel Obstruction

Led by University of Tartu · Updated on 2025-03-30

120

Participants Needed

1

Research Sites

17 weeks

Total Duration

On this page

Sponsors

U

University of Tartu

Lead Sponsor

N

North Estonia Medical Centre

Collaborating Sponsor

AI-Summary

What this Trial Is About

This trial investigates adhesive small bowel obstruction (SBO) in hospitalized patients. The study aims to evaluate the effect of timing for administering water-soluble contrast media (CM) after nasogastric tube decompression. It compares whether giving CM sooner or later helps resolve SBO without delaying necessary surgery. Patients eligible for conservative treatment are randomly assigned to receive contrast media either 4 hours or 24 hours after nasogastric decompression. X-rays are taken after the contrast media administration to assess the obstruction. If surgery becomes necessary at any point, it will not be delayed. Participants will be monitored during their hospital stay, typically about 5 days, to track SBO resolution. Researchers collect clinical, laboratory, and radiologic data to evaluate outcomes. The study includes safety oversight to ensure timely surgical intervention when needed.

CONDITIONS

Brief Title

Study About Contrast Media

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients 18 years or older
  • Diagnosed with adhesive small bowel obstruction by clinical, laboratory, and radiologic evaluation
  • No signs of peritonitis or need for emergency surgery
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Patients younger than 18 years
  • Mechanical small bowel obstruction caused by incarcerated hernias
  • Mechanical small bowel obstruction caused by carcinomatosis
  • Paralytic small bowel obstruction
  • Surgery within the last 6 weeks
  • Patients who do not want to be enrolled in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Approximately 5 days (period of hospitalization)

Participants will receive contrast media either after 4 hours or after 24 hours of nasogastric decompression as part of their management for adhesive small bowel obstruction. Surgery will be performed immediately if needed and will not be delayed.

Daily visits during hospitalization

Trial Site Locations

Total: 1 location

1

Tartu University Hospital

Tartu, Tartu, Estonia, 50406

Actively Recruiting

Loading map...

Research Team

L

Liis Jaanimäe, MD

C

Ceith Nikkolo, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

Impact of a Procalcitonin-based Algorithm on Quality of Mana...

Small Bowel Obstruction

Actively Recruiting

1 location

Contribution of Point of Care Ultrasound by the Emergency Ph...

Small Bowel Obstruction

Actively Recruiting

18 locations

Early Surgery Versus 3 Days Non-surgical Management in Acute...

Small Bowel Obstruction

Actively Recruiting

14 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here